NCT06292117View on ClinicalTrials.gov

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Ischemic StrokeCYP2C19 Polymorphism
Interventions
OTHER

CYP2C19 Genotype

qPCR-based genotyping assay interrogating all Association for Molecular Pathology (AMP) recommended Tier 1 and Tier 2 single nucleotide polymorphisms (SNPs) for CYP2C19 (\*2, \*3, \*4, \*5, \*6, \*7, \*8, \*9, \*10, \*17, \*35)

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Virginia

OTHER